Berkshire’s $6.8B Taylor Morrison deal signals value in profitable homebuilders. Green Brick offers superior profitability.

Hinge Health continues to outperform expectations and strengthen its growth trajectory each quarter. Read why HNGE stock is a ...

Elon Musk's SpaceX (SPCX) plans to price its IPO at $135 per share, raising ~$75B through the sale of about 555.6M shares, ...

Palantir at a $369B valuation requires federal market share and commercial scale that defy historical and regulatory ...

Carvana (CVNA) gains as used-car prices stay strong; Manheim Index hits 2-year high and inventory stays tight. See here for ...

Willis Towers Watson remains a 'buy' despite a 20% share price decline and persistent AI disintermediation fears. WTW's ...

CoreWeave Q1 revenue surged 112% as AI demand lifts bookings and backlog; risks include leverage and capex. Read here for ...

Key risks include hyperscaler CapEx volatility, regulatory intervention, and valuation sensitivity despite the recent ...

Lazard US Equity Focus Portfolio fell 5.0% in Q1, lagging the S&P 500 due to AI disruption fears and geopolitical risks. Read ...

MannKind’s Afrezza wins FDA approval for pediatric use—unlocking growth and a $300–500M opportunity. Read here for more on ...

Northern Funds Active M Emerging Markets Equity Fund returned 4.62% in Q1 2026, significantly outperforming its benchmark.

Campbell Soup (CPB) analysis: improved capital allocation and safe dividend, but weak sentiment and legacy brands may limit ...